Public tenders in Germany

946 open tenders

CountryTenderValueClosesDays left

Conclusion of a non-exclusive discount agreement under § 130a, para. 8 of the German Social Security Code (SGB V) for the active substance Olanzapine (excluding Dafo. TRS), ATC code N05AH03 for the period 01.09.2026 - 31.08.2028 (including V.-option 1x12 months)

DAK-Gesundheit, HamburgTED 494411-2026

€11 lot, 2 years

Thu 5 Jul12:00 in Berlin

980days

Conclusion of a non-exclusive discount agreement pursuant to § 130a Abs. 8 SGB V for the active substance Budesonide + Formoterol (excluding IHP in the strength 80 µg/4, 5 µg), ATC R03AK07 for the period 1.10.26 - 30.09.28

DAK-Gesundheit, HamburgTED 569675-2026

€11 lot, 2 years

Sun 5 Aug12:00 in Berlin

1011days

Conclusion of a non-exclusive discount agreement pursuant to § 130a Abs. 8 SGB V for the active substance Piracetam, ATC N06BX03 for the period 01.10.2026 - 30.09.2028 (including extension option 1x12 months)

DAK-Gesundheit, HamburgTED 570333-2026

€11 lot, 2 years

Sun 5 Aug12:00 in Berlin

1011days

Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 of the German Social Code Book V (SGB V) for the active substance Betahistine (excluding strengths 6 mg and 12 mg) for the period 01.10.2026 – 30.09.2028 (plus extension option 1x12 months)

DAK-Gesundheit, HamburgTED 570684-2026

€11 lot, 2 years

Sun 5 Aug12:00 in Berlin

1011days

Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 of the German Social Code Book V (SGB V) for the active substance Dydrogesterone, ATC G03DB01, for the period 01.10.2026 – 30.09.2028 (plus extension option 1x12 months)

DAK-Gesundheit, HamburgTED 571940-2026

€11 lot, 2 years

Sun 5 Aug12:00 in Berlin

1011days

Conclusion of a non-exclusive discount agreement pursuant to § 130a Abs. 8 SGB V for the active substance Brimonidine (excluding DaFo single doses), ATC S01EA05 for the period 01.10.26 - 30.09.28 (including V.-option 1x12 months)

DAK-Gesundheit, HamburgTED 569456-2026

€11 lot, 2 years

Sun 5 Aug12:00 in Berlin

1011days

Conclusion of a non-exclusive discount agreement pursuant to § 130a Abs. 8 SGB V for the active substance Baclofen (excluding oral Dafo.), ATC M03BX01 for the period 01.10.26 - 30.09.28 (including V.-option 1x12 months)

DAK-Gesundheit, HamburgTED 569918-2026

€11 lot, 2 years

Sun 5 Aug12:00 in Berlin

1011days

Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 of the German Social Code Book V (SGB V) for the active substance Formoterol (excluding IHP at strength 6 µg), ATC R03AC13, for the period 1.10.26–30.9.28 (plus extension option 1x12 months)

DAK-Gesundheit, HamburgTED 571635-2026

€11 lot, 2 years

Sun 5 Aug12:00 in Berlin

1011days

Conclusion of a non-exclusive discount agreement pursuant to § 130a Abs. 8 SGB V for the active substance Fampridin (excluding 14 pieces + 112 pieces), ATC N07XX07 for the period from 01.11.26 to 31.10.28 (including V.-option 1x12 months)

DAK-Gesundheit, HamburgTED 644787-2026

€11 lot, 2 years

Wed 5 Sep12:00 in Berlin

1042days

Conclusion of a non-exclusive discount agreement pursuant to § 130a Abs. 8 SGB V for the active ingredient Nadroparin, ATC B01AB06, valid from 01.11.26 to 31.10.28 (including V.-Option 1x12 Mon)

DAK-Gesundheit, HamburgTED 640827-2026

€11 lot, 2 years

Wed 5 Sep12:00 in Berlin

1042days

Conclusion of a non-exclusive discount agreement pursuant to § 130a Abs. 8 SGB V for the active substance Sulfasalazine (excluding FMR, N2), ATC M01CX02 for the period from 01.11.26 to 31.10.28 (including V.-option 1x12 months)

DAK-Gesundheit, HamburgTED 645197-2026

€11 lot, 2 years

Wed 5 Sep12:00 in Berlin

1042days

Conclusion of a non-exclusive discount agreement pursuant to § 130a Abs. 8 SGB V for the active ingredient Cinacalcet (excluding the standard size N3), ATC H05BX01, valid from 01.11.26 to 31.10.28 (including V.-Option 1x12 Mon)

DAK-Gesundheit, HamburgTED 640982-2026

€11 lot, 2 years

Wed 5 Sep12:00 in Berlin

1042days

Conclusion of a non-exclusive discount agreement pursuant to § 130a Abs. 8 SGB V for the active ingredient Thalidomid, ATC L04AX02, valid from 01.11.26 to 31.10.28 (including V.-Option 1x12 Mon)

DAK-Gesundheit, HamburgTED 642751-2026

€11 lot, 2 years

Wed 5 Sep12:00 in Berlin

1042days

Conclusion of a non-exclusive discount agreement pursuant to § 130a Abs. 8 SGB V for the active substance Interferon beta-1a (exclusively for subcutaneous use), ATC L03AB07 for the period from 01.11.26 to 31.10.28

DAK-Gesundheit, HamburgTED 644964-2026

€11 lot, 2 years

Wed 5 Sep12:00 in Berlin

1042days

Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 SGB V for the active ingredient dihydrocodeine, ATC R05DA14 for the period 01.12.2026 - 30.11.2028 (plus extension option 1x12 months)

DAK-Gesundheit, HamburgTED 712475-2026

€11 lot, 2 years

Fri 5 Oct12:00 in Berlin

1072days

Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 SGB V for the active ingredient Latanoprost (exclusively EDO 30x0,3 ml and 90x0,3ml), ATC S01EE01 for the period 01.12.2026 - 30.11.2028

DAK-Gesundheit, HamburgTED 714510-2026

€11 lot, 2 years

Fri 5 Oct12:00 in Berlin

1072days

Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 SGB V for the active ingredient clomipramine, ATC N06AA04 for the period 01.12.2026 - 30.11.2028 (plus extension option 1x12 months)

DAK-Gesundheit, HamburgTED 712872-2026

€11 lot, 2 years

Fri 5 Oct12:00 in Berlin

1072days

Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 SGB V for the active ingredient risedronic acid (excl. FTA 5mg and 75mg), ATC M05BA07 for the period 01.12.26-30.11.28 (plus extension option 1x12 months)

DAK-Gesundheit, HamburgTED 712081-2026

€11 lot, 2 years

Fri 5 Oct12:00 in Berlin

1072days

Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 SGB V for the active ingredient Apixaban, ATC B01AF02 for the period 01.12.2026 - 30.11.2028 (plus extension option 1x12 months)

DAK-Gesundheit, HamburgTED 711444-2026

€11 lot, 2 years

Fri 5 Oct12:00 in Berlin

1072days

Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 SGB V for the active ingredient ezetimibe + atorvastatin (excl. pack size 88 units), ATC C10BA05 for the period 01.12.2026 - 30.11.2028

DAK-Gesundheit, HamburgTED 712959-2026

€11 lot, 2 years

Fri 5 Oct12:00 in Berlin

1072days

SIMAP: This is not an official publication. The data published on www.simap.ch are authoritative. SIMAP data use is subject to its terms.